2022-05-13 Sale | 2022-05-17 5:12 pm | Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner | 131,650 | $10.45 | $1,375,564 | 2,155,930 (Direct) | View |
2022-05-10 Sale | 2022-05-12 8:47 pm | Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner | 160,901 | $10.39 | $1,671,824 | 2,287,580 (Direct) | View |
2022-05-05 Sale | 2022-05-09 6:58 pm | Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner | 86,677 | $10.37 | $898,921 | 2,448,481 (Direct) | View |
2022-05-02 Sale | 2022-05-04 7:30 pm | Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner | 270,675 | $10.38 | $2,809,332 | 2,535,158 (Direct) | View |
2022-04-27 Sale | 2022-04-29 5:50 pm | Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner | 190,026 | $10.38 | $1,972,579 | 2,805,833 (Direct) | View |
2022-04-22 Sale | 2022-04-26 6:40 pm | Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner | 129,781 | $10.39 | $1,347,796 | 2,995,859 (Direct) | View |
2022-04-19 Sale | 2022-04-21 8:54 pm | Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner | 547,734 | $10.41 | $5,700,491 | 3,125,640 (Direct) | View |
2021-04-27 Purchase | 2021-04-29 6:44 pm | IMPEL NEUROPHARMA INC | IMPL | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner | 450,000 | $15 | $6,750,000 | 2,759,791 (Direct) | View |
2020-08-11 Purchase | 2020-08-12 9:00 pm | Checkmate Pharmaceuticals Inc. | CMPI | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner | 200,000 | $15 | $3,000,000 | 3,673,374 (Direct) | View |
2020-07-21 Purchase | 2020-07-21 9:29 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Adelman Robert J venBio Global Strategic Fund L.P. venBio Global Strategic GP Ltd. venBio Global Strategic Fund II L.P. venBio Global Strategic GP L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. See Remarks 10% Owner | 853,000 | $19 | $16,207,000 | 5,829,542 (Indirect Direct) | View |
2020-07-01 Sale | 2020-07-06 7:00 pm | Akero Therapeutics Inc. | AKRO | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner | 116,467 | $34.4 | $4,006,537 | 3,033,552 (Indirect) | View |
2020-03-04 Sale | 2020-03-06 5:23 pm | Akero Therapeutics Inc. | AKRO | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner | 45,950 | $23.76 | $1,091,608 | 3,150,019 (Indirect) | View |
2020-02-28 Sale | 2020-03-03 5:52 pm | Akero Therapeutics Inc. | AKRO | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner | 21,798 | $22.63 | $493,310 | 3,195,969 (Indirect) | View |
2020-02-25 Sale | 2020-02-27 7:51 pm | Akero Therapeutics Inc. | AKRO | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner | 5,904 | $22.8 | $134,635 | 3,227,767 (Indirect) | View |
2020-02-10 Sale | 2020-02-12 5:56 pm | Akero Therapeutics Inc. | AKRO | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner | 10,026 | $27.07 | $271,399 | 3,233,671 (Indirect) | View |
2020-02-06 Sale | 2020-02-10 5:47 pm | Akero Therapeutics Inc. | AKRO | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner | 6,102 | $27.03 | $164,955 | 3,233,697 (Indirect) | View |
2020-02-04 Sale | 2020-02-06 4:06 pm | Akero Therapeutics Inc. | AKRO | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner | 82,339 | $25.77 | $2,121,726 | 3,239,799 (Indirect) | View |
2020-01-13 Sale | 2020-01-14 08:58 am | Akero Therapeutics Inc. | AKRO | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner | 494,000 | $20.23 | $9,993,620 | 3,322,138 (Indirect) | View |
2020-01-08 Sale | 2020-01-10 4:06 pm | Akero Therapeutics Inc. | AKRO | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner | 15,677 | $19.86 | $311,355 | 3,816,138 (Indirect) | View |
2020-01-06 Sale | 2020-01-08 4:10 pm | Akero Therapeutics Inc. | AKRO | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner | 73,221 | $19.86 | $1,454,530 | 3,831,815 (Indirect) | View |
2020-01-02 Sale | 2020-01-06 4:07 pm | Akero Therapeutics Inc. | AKRO | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner | 35,498 | $19.71 | $699,721 | 3,905,036 (Indirect) | View |
2019-12-31 Sale | 2020-01-03 4:13 pm | Akero Therapeutics Inc. | AKRO | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner | 14,324 | $23.96 | $343,259 | 3,940,534 (Indirect) | View |